Dr. Selwyn M. Vickers

Dr. Selwyn M. Vickers, MD, FACS, is a nationally recognized surgeon and academic leader specializing in pancreatic diseases and cancer. He serves as President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center, where he is responsible for guiding one of the world’s leading institutions in cancer research, education, and clinical care. Dr. Vickers earned his medical degree from Johns Hopkins University School of Medicine, where he also completed his surgical residency and a fellowship in surgical oncology. He is board-certified in General Surgery and has held prominent leadership roles, including Senior Vice President for Medicine and Dean of the School of Medicine at the University of Alabama at Birmingham (UAB).

A highly regarded investigator, Dr. Vickers has focused his research on understanding pancreatic cancer biology and developing novel therapeutic strategies. He has led NIH- and foundation-funded studies that have advanced knowledge of pancreatic tumor growth and resistance pathways. His work has helped shape approaches to treating pancreatic cancer, and he has published extensively in leading medical and surgical journals. Dr. Vickers has also played an active role in addressing cancer disparities, advocating for improved access to care and equity in health outcomes for underserved populations.

In addition to his research and clinical contributions, Dr. Vickers is a dedicated educator, mentor, and national leader in academic medicine. He has trained numerous surgical residents and fellows who have gone on to leadership roles across the country. He has served on advisory boards for the National Cancer Institute, the NIH Council of Councils, and professional organizations including the American Surgical Association and the American College of Surgeons. Elected to the National Academy of Medicine, he is widely recognized for his commitment to advancing cancer research, health equity, and academic leadership. Through his vision and stewardship, Dr. Selwyn M. Vickers continues to shape the future of surgical oncology and cancer care delivery.